MASAN: a novel staging system for prognosis of patients with oesophageal squamous cell carcinoma.

ABSTRACT: BACKGROUND:Oesophageal squamous cell carcinoma (ESCC) is one of the most malignant cancers worldwide. Treatment of ESCC is in progress through accurate staging and risk assessment of patients. The emergence of potential molecular markers inspired us to construct novel staging systems with better accuracy by incorporating molecular markers. METHODS:We measured H scores of 23 protein markers and analysed eight clinical factors of 77 ESCC patients in a training set, from which we identified an optimal MASAN (MYC, ANO1, SLC52A3, Age and N-stage) signature. We constructed MASAN models using Cox PH models, and created MASAN-staging systems based on k-means clustering and minimum-distance classifier. MASAN was validated in a test set (n?=?77) and an independent validation set (n?=?150). RESULTS:MASAN possessed high predictive accuracies and stratified ESCC patients into three prognostic groups that were more accurate than the current pTNM-staging system for both overall survival and disease-free survival. To facilitate clinical utilisation, we also constructed MASAN-SI staging systems based on staining indices (SI) of protein markers, which possessed similar prognostic performance as MASAN. CONCLUSION:MASAN provides a good alternative staging system for ESCC prognosis with a high precision using a simple model.

SUBMITTER: Liu W 

PROVIDER: S-EPMC5988697 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature